drugset / Trial / NCT00771004

Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

NCT00771004

Phase 2 Completed 63 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effects of pioglitazone, once daily (QD), on heart functioning before, during and after stent implantation.

Timeline

Start
2006-08
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 45 mg Oral